Every 8-K that AptarGroup, Inc. (ATR) has filed with the SEC in the last 24 months is listed below, newest first, and each one links through to the document itself with the summary and the scores our analysis gives it.
A 8-K covers material events a company has to report between its quarterly reports, so if you follow ATR and want that one kind of document rather than the whole filing history, this is the page to keep. The company's other filings, of every form, are on the full ATR filings page.
APTARGROUP, INC. (ATR) reported that Aditya J. Gandhi, Vice President, Chief Accounting Officer and principal accounting officer, has decided to resign effective September 11, 2026 to pursue another opportunity outside the greater Chicago area. The company states his resignation is not due to any disagreement regarding operations, policies or practices.
Effective as of the separation date, the Board appointed Daniel Ackerman
APTARGROUP, INC. (ATR) reported that its Board of Directors increased in size from 10 to 11 members and appointed Gael Touya as a director, effective September 1, 2026. Touya will serve until the company’s 2028 annual meeting of stockholders and until his successor is elected and qualified. He is not expected to serve on any Board committee. Touya, who became President and Chief Executive Officer on September 1, 2026, has no disclosed family relationships with directors or executive officers and no related-party transactions requiring disclosure under Item 404(a) of Regulation S-K. As an employee, he will not receive additional compensation for his Board service; his CEO compensation was disclosed in an earlier Form 8-K.
AptarGroup, Inc. appointed Aditya J. Gandhi as Vice President, Chief Accounting Officer, effective June 8, 2026, succeeding Daniel Ackerman, who is moving to another leadership role within the Aptar finance organization. Gandhi will serve as principal accounting officer and report to CFO Vanessa Kanu.
Gandhi, age 46, previously served as Chief Accounting Officer of Sonoco Products Company and held senior roles at WestRock, General Electric and Deloitte. His offer includes a one-time cash sign-on bonus of $105,000 and a one-time equity award with a grant-date fair value of $715,000, split into $305,000 in restricted stock units and $410,000 in performance-based restricted stock units.
AptarGroup, Inc. held its Annual Meeting of Stockholders on May 6, 2026, where shareholders elected four directors to serve until the 2029 Annual Meeting. All nominees, including George L. Fotiades, Candace Matthews, B. Craig Owens, and Julie Xing, received strong majority support.
Stockholders also approved, on an advisory basis, the Company’s executive compensation program and ratified the appointment of PricewaterhouseCoopers LLP as independent registered public accounting firm for the fiscal year ending December 31, 2026.
AptarGroup reported mixed first quarter 2026 results, with solid top-line growth but softer profit metrics. Net sales rose 11% to $982.9 million, while reported net income declined 8% to $72.8 million and diluted earnings per share slipped to $1.12 from $1.17.
On an adjusted basis, earnings per share were $1.19, down from $1.30 a year earlier at comparable exchange rates, and adjusted EBITDA margin narrowed to 19.2% from 20.7% as mix and operational issues weighed on profitability. Pharma and Closures saw core sales pressure from emergency medicine destocking, lower resin pricing and temporary plant disruptions, while Beauty delivered 3% core growth.
The company returned $131 million to shareholders through dividends and share repurchases in the quarter, including buying back 707,000 shares for $100 million, and the board approved a quarterly dividend of $0.48 per share. For the second quarter of 2026, AptarGroup expects adjusted earnings per share between $1.32 and $1.40, assuming an effective tax rate of 22.5% to 24.5% and a 1.18 EUR/USD exchange rate. The company also announced that Gael Touya will become CEO effective September 1, 2026.
AptarGroup, Inc. is planning a CEO transition. Stephan Tanda notified the Board of his intention to retire as President and CEO effective September 1, 2026. The Board appointed Gael Touya, currently President of Aptar Pharma, to become President and CEO on that date and expects to add him to the Board.
Touya’s employment agreement runs initially through December 31, 2028, with potential extensions, and provides an initial base salary of $1,060,000, a 2026 bonus target at 120% of base salary and a long‑term incentive target of at least 500% of base salary. The company will make a nonqualified deferred compensation contribution equal to €2,506,320 (subject to update) in lieu of his French defined benefit plans, and outlines severance and change‑in‑control protections.
Tanda will remain employed as a strategic advisor and Board member through December 31, 2026, with 2026 incentive opportunities based on his existing compensation levels. To support leadership continuity, Chief Financial Officer Vanessa Kanu and Aptar Closures President Hedi Tlili each received a one‑time restricted stock unit grant with a grant date fair value of $1.3 million, vesting after two or three years.
AptarGroup reported solid 2025 growth with some margin pressure. Fourth quarter 2025 sales rose 14% to $962.7 million, but net income fell to $74.3 million and diluted EPS declined to $1.13 from $1.49 as mix and higher production costs weighed on profitability.
For full-year 2025, sales increased 5% to $3.78 billion and diluted EPS grew 7% to $5.89, while adjusted EPS slipped 1% to $5.74. Pharma, Beauty and Closures all delivered core sales growth, and adjusted EBITDA margin held at 21.6%. The company generated $570 million in operating cash flow and $302.9 million in free cash flow, ended the year with $410 million in cash and short-term investments and net debt of $1.07 billion, and reported a leverage ratio of 1.38. Aptar returned $486 million to shareholders via dividends and buybacks in 2025, including repurchasing 1.5 million shares for $175 million in the fourth quarter, and its board approved a new authorization to repurchase up to $600 million of common stock. The company guided first quarter 2026 adjusted EPS to $1.13–$1.21 and plans 2026 capital investments of $260–$280 million.
AptarGroup, Inc. completed an underwritten public offering of $600 million aggregate principal amount of its 4.750% Senior Notes due 2031. The notes mature on March 30, 2031 and carry a fixed interest rate of 4.750% per year, paid semi-annually on March 30 and September 30, starting March 30, 2026. These notes are unsecured and rank equally with the company’s other senior unsecured debt.
The company can redeem the notes before February 28, 2031 at a make-whole price, and on or after that date at 100% of principal plus accrued interest. If a defined change of control repurchase event occurs and the notes are not redeemed, holders can require AptarGroup to repurchase their notes at 101% of principal plus accrued interest. The indenture includes typical covenants limiting certain liens, sale-leaseback transactions, and major corporate reorganizations, along with standard events of default and acceleration provisions.
AptarGroup, Inc. (ATR) furnished an 8-K announcing that it released certain information related to its results of operations for the quarter ended September 30, 2025. The company provided a press release as Exhibit 99.1.
The company stated the furnished information in Item 2.02 and Exhibit 99.1 is not deemed “filed” under Section 18 of the Exchange Act and is not incorporated into other filings unless specifically referenced. AptarGroup’s common stock trades on the NYSE under the symbol ATR.